Telemedicine's Role in Addressing the Opioid Epidemic.
作者信息
Yang Y Tony, Weintraub Eric, Haffajee Rebecca L
机构信息
Center for Health Policy and Media Engagement, George Washington University School of Nursing, Washington, DC; Department of Health Policy and Management, George Washington University Milken Institute School of Public Health, Washington, DC.
Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Md.
出版信息
Mayo Clin Proc. 2018 Sep;93(9):1177-1180. doi: 10.1016/j.mayocp.2018.07.001. Epub 2018 Aug 7.
Abstract
摘要
相似文献
1
Telemedicine's Role in Addressing the Opioid Epidemic.
Mayo Clin Proc. 2018 Sep;93(9):1177-1180. doi: 10.1016/j.mayocp.2018.07.001. Epub 2018 Aug 7.
2
Characteristics and current clinical practices of opioid treatment programs in the United States.
Drug Alcohol Depend. 2019 Dec 1;205:107616. doi: 10.1016/j.drugalcdep.2019.107616. Epub 2019 Oct 17.
3
Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.
Pediatr Rev. 2018 Jan;39(1):43-45. doi: 10.1542/pir.2017-0153.
4
Update on Barriers to Pharmacotherapy for Opioid Use Disorders.
Curr Psychiatry Rep. 2017 Jun;19(6):35. doi: 10.1007/s11920-017-0783-9.
5
Maintenance medication for opiate addiction: the foundation of recovery.
J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598.
6
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Pharmacotherapy. 2017 Jul;37(7):824-839. doi: 10.1002/phar.1958. Epub 2017 Jul 2.
7
Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
Addiction. 2014 Jan;109(1):88-9. doi: 10.1111/add.12376.
8
Overview of Drugs Used to Treat Opioid Use Disorder.
Am J Nurs. 2018 Aug;118(8):25. doi: 10.1097/01.NAJ.0000544161.29445.db.
9
Use and misuse of opioid agonists in opioid addiction.
Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091.
10
Commentary on Freelemyer et al. (2014): medication-assisted treatment in Africa-need is growing but response remains tepid.
Addiction. 2014 Jan;109(1):33-4. doi: 10.1111/add.12364.
引用本文的文献
1
Feasibility and acceptability of a novel digital therapeutic combining behavioral and pharmacological treatment for opioid use disorder.
Digit Health. 2024 May 29;10:20552076241258400. doi: 10.1177/20552076241258400. eCollection 2024 Jan-Dec.
2
County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities.
PLoS One. 2024 Apr 5;19(4):e0301863. doi: 10.1371/journal.pone.0301863. eCollection 2024.
3
A Review of Telemedicine Guidelines in the South-East Asia Region.
Telemed Rep. 2023 Sep 25;4(1):271-278. doi: 10.1089/tmr.2023.0040. eCollection 2023.
4
Telehealth Initiation of Buprenorphine for Opioid Use Disorder: Patient Characteristics and Outcomes.
J Gen Intern Med. 2024 Jan;39(1):95-102. doi: 10.1007/s11606-023-08383-1. Epub 2023 Sep 5.
5
The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review.
Curr Addict Rep. 2023;10(2):187-197. doi: 10.1007/s40429-023-00480-9. Epub 2023 Apr 25.
6
Patient evaluation of a smartphone application for telehealth care of opioid use disorder.
Addict Sci Clin Pract. 2022 Sep 9;17(1):50. doi: 10.1186/s13722-022-00331-4.
7
Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions.
West J Emerg Med. 2022 Jul 11;23(4):461-467. doi: 10.5811/westjem.2022.2.52978.
8
Virtual opioid agonist treatment: Alberta's virtual opioid dependency program and outcomes.
Addict Sci Clin Pract. 2022 Jul 28;17(1):40. doi: 10.1186/s13722-022-00323-4.
9
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.
NAM Perspect. 2020 Apr 27;2020. doi: 10.31478/202004b. eCollection 2020.
10
A Blueprint for the Conduct of Large, Multisite Trials in Telemedicine.
J Med Internet Res. 2021 Sep 20;23(9):e29511. doi: 10.2196/29511.
本文引用的文献
1
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017.
MMWR Morb Mortal Wkly Rep. 2018 Mar 9;67(9):279-285. doi: 10.15585/mmwr.mm6709e1.
2
The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting.
Drug Alcohol Depend. 2017 Jul 1;176:133-138. doi: 10.1016/j.drugalcdep.2017.01.048. Epub 2017 May 17.
3
Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.
J Addict Med. 2017 Mar/Apr;11(2):138-144. doi: 10.1097/ADM.0000000000000287.
4
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.
Am J Public Health. 2015 Aug;105(8):e55-63. doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.
5
The untapped potential of office-based buprenorphine treatment.
JAMA Psychiatry. 2015 Apr;72(4):395-6. doi: 10.1001/jamapsychiatry.2014.2421.
6
The effectiveness of telemental health: a 2013 review.
Telemed J E Health. 2013 Jun;19(6):444-54. doi: 10.1089/tmj.2013.0075.
7
Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009.
Am J Public Health. 2013 May;103(5):917-22. doi: 10.2105/AJPH.2012.301049. Epub 2013 Mar 14.
8
Oral naltrexone maintenance treatment for opioid dependence.
Cochrane Database Syst Rev. 2011 Apr 13;2011(4):CD001333. doi: 10.1002/14651858.CD001333.pub4.
9
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Cochrane Database Syst Rev. 2004(3):CD002207. doi: 10.1002/14651858.CD002207.pub2.
Zotero 插件